BeiGene Announces U.S. FDA Acceptance of Supplemental New Drug Application for BRUKINSA (zanubrutinib) in Chronic Lymphocytic Leukemia
The filing is supported by two global Phase 3 trials of BRUKINSA in chronic lymphocytic…
The filing is supported by two global Phase 3 trials of BRUKINSA in chronic lymphocytic…
HONG KONG SAR - Media OutReach - 22 February 2022 - The 20-year-old NBA All-Star…
DUBLIN--(BUSINESS WIRE)--The "India Probiotics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report…
SAN JOSE, Calif.--(BUSINESS WIRE)--QuantumScape Corporation (NYSE: QS), a leader in developing next-generation solid-state lithium-metal batteries…
DUBLIN--(BUSINESS WIRE)--The "Global Companion Diagnostics Market by Product (Assays, Kits, Software & Services), Technology (PCR,…
? Proposed acquisition of a local renowned insurance company’s general insurance business portfolio for about…
LONDON & NEW YORK & HONG KONG--(BUSINESS WIRE)--Options Technology, the leading provider of cloud-enabled managed…
DUBLIN--(BUSINESS WIRE)--The "Southeast Asia Agriculture Equipment Market - Strategic Assessment & Forecast 2022-2028" report has…
Leaders in ophthalmology drug development launch new global company to build and advance diversified portfolio…
First carbon-neutral automobile ABS on the Shenzhen Stock Exchange GUANGZHOU, China--(BUSINESS WIRE)--$XPEV #EV--XPeng Inc. (“XPeng”…